Grzegorz S Nowakowski, MD

  • 4142 Citations
  • 40 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2001 2019

  • 4142 Citations
  • 40 Scopus h-Index
  • 124 Article
  • 7 Review article
  • 3 Letter
  • 1 Comment/debate
2019

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease
10 Citations (Scopus)

AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., Pinto, A., Re, F., Fogliatto, L. M., Scheinberg, P., Flinn, I. W., Moreira, C., Cabeçadas, J., Liu, D., Kalambakas, S., Fustier, P. & 2 others, Wu, C. & Gribben, J. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1188-1199 12 p.

Research output: Contribution to journalArticle

Open Access
Lymphoma
Placebos
Neutropenia
Disease-Free Survival
lenalidomide
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival

End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma

Kostakoglu, L. & Nowakowski, G. S., Jul 1 2019, In : PET Clinics. 14, 3, p. 307-315 9 p.

Research output: Contribution to journalReview article

Lymphoma, Large B-Cell, Diffuse
tomography
Tomography
Disease-Free Survival
progressions

Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma

Wang, Y., Maurer, M. J., Larson, M. C., Allmer, C., Feldman, A. L., Bennani, N., Thompson, C. A., Porrata, L. F., Habermann, T. M., Witzig, T. E., Ansell, S. M., Slager, S. L., Nowakowski, G. S. & Cerhan, J. R., Sep 1 2019, In : British journal of haematology. 186, 6, p. 820-828 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Metformin
Diabetes Mellitus
Confidence Intervals

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

Nowakowski, G. S., Feldman, T., Rimsza, L., Westin, J. R., Witzig, T. E. & Zinzani, P. L., Jun 1 2019, In : Blood cancer journal. 9, 6, 48.

Research output: Contribution to journalReview article

Open Access
Precision Medicine
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Therapeutics
Germinal Center
1 Citation (Scopus)

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Recurrence
Germinal Center
B-Lymphocytes

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Hodgkin Disease
Biopsy
Salvage Therapy
Therapeutics
Positron Emission Tomography Computed Tomography
20 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio
2018
2 Citations (Scopus)

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses

McCarter, S. J., Vijayvargiya, P., Sidana, S., Nault, A. M., Lane, C. E., Lehman, J., Wilson, J. W., Parikh, S. A., Nowakowski, G. S. & Al-Kali, A., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Aspergillosis
Abscess
Central Nervous System
Lung
PCI 32765
3 Citations (Scopus)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, M. L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

Hodgkin Disease
Programmed Cell Death 1 Receptor
Antibodies
Secondary Prevention
Radiotherapy

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
4 Citations (Scopus)

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 63.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Central Nervous System
Recurrence
lenalidomide
Open Access
Names
Retina
Lymphoma
Publications
4-iodo-2,5-dimethoxyphenylisopropylamine
21 Citations (Scopus)

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias
27 Citations (Scopus)

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology

Scott, D. W., King, R., Staiger, A. M., Ben-Neriah, S., Jiang, A., Horn, H., Mottok, A., Farinha, P., Slack, G. W., Ennishi, D., Schmitz, N., Pfreundschuh, M., Nowakowski, G. S., Kahl, B. S., Connors, J. M., Gascoyne, R. D., Ott, G., Macon, W. R. & Rosenwald, A., May 3 2018, In : Blood. 131, 18, p. 2060-2064 5 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Tumors
Cells
3 Citations (Scopus)

History of autoimmune conditions and lymphoma prognosis

Kleinstern, G., Maurer, M. J., Liebow, M., Habermann, T. M., Koff, J. L., Allmer, C., Witzig, T. E., Nowakowski, G. S., Micallef, I., Johnston, P. B., Inwards, D. J., Thompson, C. A., Feldman, A. L., Link, B. K., Flowers, C., Slager, S. L. & Cerhan, J. R., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 73.

Research output: Contribution to journalArticle

Lymphoma
Disease-Free Survival
Hodgkin Disease
B-Lymphocytes
Survival
7 Citations (Scopus)

Human Pegivirus infection and lymphoma risk and prognosis: A North American study

Fama, A., Xiang, J., Link, B. K., Allmer, C., Klinzman, D., Feldman, A. L., Nowakowski, G. S., Liebow, M., Larson, M. C., Maurer, M. J., Ansell, S. M., Novak, A. J., Asmann, Y., Slager, S. L., Call, T. G., Habermann, T. M., Cerhan, J. R. & Stapleton, J. T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Lymphoma
Infection
Viremia
B-Cell Chronic Lymphocytic Leukemia
Confidence Intervals

Identification of Factors Associated with Hematology-Oncology Fellow Academic Success and Career Choice

Marshall, A. L., Gupta, R., Grill, D., Mann, S., Freidline, K., Nowakowski, G. S., Thompson, C. A. & Hobday, T. J., Jan 1 2018, (Accepted/In press) In : Journal of Cancer Education.

Research output: Contribution to journalArticle

Career Choice
Hematology
Licensure
Internship and Residency
Publications
10 Citations (Scopus)

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

McPhail, E., Maurer, M. J., Macon, W. R., Feldman, A. L., Kurtin, P. J., Ketterling, R. P., Vaidya, R., Cerhan, J. R., Ansell, S. M., Porrata, L. F., Nowakowski, G. S., Witzig, T. E. & Habermann, T. M., Nov 1 2018, In : Haematologica. 103, 11, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

Gene Rearrangement
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Vincristine
Survival
5 Citations (Scopus)

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, G., Habermann, T. M. & 3 others, Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Nov 1 2018, In : Blood Cancer Journal. 8, 11, 108.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Survival
Neoplasms
Germinal Center
Lymphoma, Large B-Cell, Diffuse
Omega-3 Fatty Acids
Biomarkers
Lymphoma
Disease-Free Survival
4 Citations (Scopus)

Outcomes among North American patients with diffuse large b-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

Tracy, S. I., Habermann, T. M., Feldman, A. L., Maurer, M. J., Dogan, A., Perepu, U. S., Syrbu, S., Ansell, S. M., Thompson, C. A., Weiner, G. J., Nowakowski, G. S., Allmer, C., Slager, S. L., Witzig, T. E., Cerhan, J. R. & Link, B. K., Jan 31 2018, In : Haematologica. 103, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

Oncogenic Viruses
Lymphoma, Large B-Cell, Diffuse
Human Herpesvirus 4
Immunosuppression
Confidence Intervals

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Zanwar, S., Abeykoon, J. P., Ansell, S. M., Gertz, M., Dispenzieri, A., Muchtar, E., Sidana, S., Tandon, N., Rajkumar, S. V., Dingli, D. M., Go, R., Lacy, M., Kourelis, T., Witzig, T. E., Inwards, D., Buadi, F., Gonsalves, W., Habermann, T. M., Johnston, P. B., Nowakowski, G. S. & 3 others, Kyle, R. A., Kumar, S. K. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Primary amyloidosis
2 Citations (Scopus)

Rapid, real time pathology review for ECOG/ACRIN 1412: A novel and successful paradigm for future lymphoma clinical trials in the precision medicine era

King, R., Nowakowski, G. S., Witzig, T. E., Scott, D. W., Little, R. F., Hong, F., Gascoyne, R. D., Kahl, B. S. & Macon, W. R., Mar 1 2018, In : Blood Cancer Journal. 8, 3, 27.

Research output: Contribution to journalReview article

Precision Medicine
Lymphoma
Clinical Trials
Pathology
Gene Expression Profiling
9 Citations (Scopus)

Recurrent stat3-jak2 fusions in indolent t-cell lymphoproliferative disorder of the gastrointestinal tract

Sharma, A., Oishi, N., Luchtel, R., Hu, G., Benson, H. K., Ketterling, R. P., Greipp, P. T., Knutson, D. L., Kloft-Nelson, S. M., He, R., Eckloff, B. W., Jen, J., Nair, A. A., Davila, J. I., Dasari, S., Lazaridis, K. N., Bennani, N., Wu, T-T., Nowakowski, G. S., Murray, J. A. & 1 others, Feldman, A. L., May 17 2018, In : Blood. 131, 20

Research output: Contribution to journalLetter

Janus Kinase 2
STAT3 Transcription Factor
T-cells
Fusion reactions
3 Citations (Scopus)
Methotrexate
Lymphoma
Survival
Central Nervous System
Recurrence
1 Citation (Scopus)

T cell/histiocyte-rich large B cell lymphoma: Incidence, demographic disparities, and long-term outcomes

Kommalapati, A., Tella, S. H., Go, R. S., Nowakowski, G. S. & Goyal, G., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Histiocytes
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Hodgkin Disease
Demography
5 Citations (Scopus)

The diagnosis and treatment of primary vitreoretinal lymphoma: A review

Pulido, J. S., Johnston, P. B., Nowakowski, G. S., Castellino, A. & Raja, H., Jan 1 2018, In : International Journal of Retina and Vitreous. 4, 1, 18.

Research output: Contribution to journalReview article

Lymphoma
Methotrexate
Therapeutics
Central Nervous System
Mutation
8 Citations (Scopus)

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

El-Galaly, T. C., Cheah, C. Y., Bendtsen, M. D., Nowakowski, G. S., Kansara, R., Savage, K. J., Connors, J. M., Sehn, L. H., Goldschmidt, N., Shaulov, A., Farooq, U., Link, B. K., Ferreri, A. J. M., Calimeri, T., Cecchetti, C., Dann, E. J., Thompson, C. A., Inbar, T., Maurer, M. J., Gade, I. L. & 14 others, Juul, M. B., Hansen, J. W., Holmberg, S., Larsen, T. S., Cordua, S., Mikhaeel, N. G., Hutchings, M., Seymour, J. F., Clausen, M. R., Smith, D., Opat, S., Gilbertson, M., Thanarajasingam, G. & Villa, D., Apr 1 2018, In : European Journal of Cancer. 93, p. 57-68 12 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Survival
Methotrexate
Recurrence
Status Epilepticus
2017
5 Citations (Scopus)

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
Lymphoma
B-Cell Lymphoma
10 Citations (Scopus)

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy

Farooq, U., Maurer, M. J., Thompson, C. A., Thanarajasingam, G., Inwards, D. J., Micallef, I., Macon, W., Syrbu, S., Lin, T., Lin, Y., Ansell, S. M., Nowakowski, G. S., Habermann, T. M., Cerhan, J. R. & Link, B. K., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Anthracyclines
Recurrence
Survival
Transplants
14 Citations (Scopus)
cohort analysis
disease incidence
Molecular Epidemiology
epidemiology
research program
43 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
9 Citations (Scopus)

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Bennani, N., LaPlant, B. R., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Macon, W. R., Reeder, C. B., Mikhael, J. R., Northfelt, D. W., Ghobrial, I. M. & Witzig, T. E., May 1 2017, In : American Journal of Hematology. 92, 5, p. 448-453 6 p.

Research output: Contribution to journalArticle

Lymphoma
Therapeutics
Safety
Febrile Neutropenia
Everolimus
2 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Lymphoma
Central Nervous System
Clinical Trials
13 Citations (Scopus)

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

Bryce, A. H., Egan, J. B., Borad, M. J., Stewart, A. K., Nowakowski, G. S., Chanan Khan, A. A., Patnaik, M. M., Ansell, S. M., Banck, M. S., Robinson, S., Mansfield, A., Klee, E. W., Oliver, G. R., McCormick, J. B., Huneke, N. E., Tagtow, C. M., Jenkins, R. B., Rumilla, K. M., Kerr, S. E., Kocher, J-P. & 5 others, Beck, S. A., Fernandez-Zapico, M. E., Farrugia, G., Lazaridis, K. N. & Mc Williams, R. R., 2017, In : Oncotarget. 8, 16, p. 27145-27154 10 p.

Research output: Contribution to journalArticle

Genomics
Neoplasms
Precision Medicine
Standard of Care
Therapeutics
2 Citations (Scopus)

Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab

Malecek, M. K., Petrich, A. M., Rozell, S., Chu, B., Trifilio, S., Galanina, N., Maurer, M., Farooq, U., Link, B. K., Nowakowski, G. S., Nabhan, C. & Ayed, A. O., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Recurrence
Vincristine
Etoposide
7 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Everolimus
94 Citations (Scopus)

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W. D., LaPlant, B. R., Call, T. G., Parikh, S. A., Leis, J. F., He, R., Shanafelt, T. D., Sinha, S., Le-Rademacher, J., Feldman, A. L., Habermann, T. M., Witzig, T. E., Wiseman, G. A., Lin, Y., Asmus, E., Nowakowski, G. S., Conte, M. J., Bowen, D. A., Aitken, C. N., Van Dyke, D. L. & 15 others, Greipp, P. T., Liu, X., Wu, X., Zhang, H., Secreto, C. R., Tian, S., Braggio, E. D., Wellik, L. E., Micallef, I., Viswanatha, D. S., Yan, H. D., Chanan Khan, A. A., Kay, N. E., Dong, H. M. & Ansell, S. M., Jun 29 2017, In : Blood. 129, 26, p. 3419-3427 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Tumors
Blocking Antibodies
Ligands
pembrolizumab
3 Citations (Scopus)

Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma

Nowakowski, G. S. & Vitolo, U., Apr 1 2017, In : Future Oncology. 13, 10, p. 859-862 4 p.

Research output: Contribution to journalReview article

Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Clinical Studies
2 Citations (Scopus)
T-Cell Lymphoma
Retinoids
Cell Cycle
Peripheral T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
6 Citations (Scopus)

Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma

Epperla, N., Pham, A. Q., Burnette, B. L., Wiseman, G. A., Habermann, T. M., Macon, W. R., Ansell, S. M., Inwards, D. J., Micallef, I., Johnston, P. B., Markovic, S. N., Porrata, L. F., Colgan, J. P., Ristow, K. M., Nowakowski, G. S. & Witzig, T. E., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Therapeutics
18 Citations (Scopus)

Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells

Shenoy, N., Bhagat, T., Nieves, E., Stenson, M., Lawson, J., Choudhary, G. S., Habermann, T. M., Nowakowski, G. S., Singh, R. J., Wu, X., Verma, A. & Witzig, T. E., Jul 21 2017, In : Blood Cancer Journal. 7, 7, p. e587

Research output: Contribution to journalArticle

Epigenomics
Ascorbic Acid
Lymphoma
Up-Regulation
Tumor Suppressor Genes
5 Citations (Scopus)

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma

Tracy, S. I., Maurer, M. J., Witzig, T. E., Drake, M. M., Ansell, S. M., Nowakowski, G. S., Thompson, C. A., Inwards, D. J., Johnston, P. B., Micallef, I., Allmer, C., MacOn, W. R., Weiner, G. J., Slager, S. L., Habermann, T. M., Link, B. K. & Cerhan, J. R., Aug 25 2017, In : Blood Cancer Journal. 7, 8, e595.

Research output: Contribution to journalArticle

Follicular Lymphoma
Vitamin D
Confidence Intervals
Lymphoma
Odds Ratio
4 Citations (Scopus)
Exome
Lymphoma, Large B-Cell, Diffuse
2016
16 Citations (Scopus)

Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages

Church, A. K., Vandermeid, K. R., Baig, N. A., Baran, A. M., Witzig, T. E., Nowakowski, G. S. & Zent, C. S., Jan 1 2016, In : Clinical and Experimental Immunology. 183, 1, p. 90-101 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Phagocytosis
Macrophages
Monoclonal Antibodies
Antibodies
21 Citations (Scopus)

Beyond RCHOP: A blueprint for diffuse large B cell lymphoma research

Nowakowski, G. S., Blum, K. A., Kahl, B. S., Friedberg, J. W., Baizer, L., Little, R. F., Maloney, D. G., Sehn, L. H., Williams, M. E., Wilson, W. H., Leonard, J. P. & Smith, S. M., Dec 1 2016, In : Journal of the National Cancer Institute. 108, 12, djw257.

Research output: Contribution to journalReview article

Lymphoma, Large B-Cell, Diffuse
Research
Proto-Oncogene Proteins c-bcl-2
Lymphoma
B-Lymphocyte Subsets
72 Citations (Scopus)

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

Maurer, M. J., Bachy, E., Ghesquières, H., Ansell, S. M., Nowakowski, G. S., Thompson, C. A., Inwards, D. J., Allmer, C., Chassagne-Clément, C., Nicolas-Virelizier, E., Sebban, C., Lebras, L., Sarkozy, C., Macon, W. R., Feldman, A. L., Syrbu, S. I., Traverse-Glehan, A., Coiffier, B., Slager, S. L., Weiner, G. J. & 5 others, Witzig, T. E., Habermann, T. M., Salles, G., Cerhan, J. R. & Link, B. K., 2016, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Follicular Lymphoma
Confidence Intervals
Molecular Epidemiology
Mortality
Survival
24 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Safety
Disease-Free Survival
National Cancer Institute (U.S.)
Everolimus